Ensysce Biosciences, Inc., was incorporated in Delaware in April 2003. The company is a clinical-stage pharmaceutical company dedicated to developing innovative solutions to relieve severe pain while reducing the risk of opioid misuse, abuse and overdose. The company is currently developing product candidates designed to improve the safety of prescription drugs.
